tradingkey.logo

Nephros Inc

NEPH
查看詳細走勢圖
5.030USD
-0.040-0.79%
收盤 12/19, 16:00美東報價延遲15分鐘
53.45M總市值
35.95本益比TTM

Nephros Inc

5.030
-0.040-0.79%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.79%

5天

+0.20%

1月

+2.24%

6月

+0.60%

今年開始到現在

+242.18%

1年

+226.62%

查看詳細走勢圖

TradingKey Nephros Inc股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Nephros Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在專業與商業服務行業排名99/156位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價7.00。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Nephros Inc評分

相關信息

行業排名
99 / 156
全市場排名
267 / 4582
所屬行業
專業與商業服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
7.000
目標均價
+41.99%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Nephros Inc亮點

亮點風險
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
業績高增長
公司營業收入穩步增長,連續3年增長41.97%
業績增長期
公司處於發展階段,最新年度總收入14.16M美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值35.95,處於3年歷史高位
機構減倉
最新機構持股4.82M股,環比減少0.60%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉82.50K股
活躍度增加
近期活躍度增加,過去20天平均換手率1.63

Nephros Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Nephros Inc簡介

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
公司代碼NEPH
公司Nephros Inc
CEOBanks (Robert)
網址https://www.nephros.com/

常見問題

Nephros Inc(NEPH)的當前股價是多少?

Nephros Inc(NEPH)的當前股價是 5.030。

Nephros Inc 的股票代碼是什麼?

Nephros Inc的股票代碼是NEPH。

Nephros Inc股票的52週最高點是多少?

Nephros Inc股票的52週最高點是6.420。

Nephros Inc股票的52週最低點是多少?

Nephros Inc股票的52週最低點是1.390。

Nephros Inc的市值是多少?

Nephros Inc的市值是53.45M。

Nephros Inc的淨利潤是多少?

Nephros Inc的淨利潤為74.00K。

現在Nephros Inc(NEPH)的股票是買入、持有還是賣出?

根據分析師評級,Nephros Inc(NEPH)的總體評級為買入,目標價格為7.000。

Nephros Inc(NEPH)股票的每股收益(EPS TTM)是多少

Nephros Inc(NEPH)股票的每股收益(EPS TTM)是0.140。
KeyAI